Serous macular detachment in branch retinal vein occlusion
- PMID: 17151490
- DOI: 10.1097/01.iae.0000254893.94013.16
Serous macular detachment in branch retinal vein occlusion
Abstract
Purpose: To evaluate the relationship between the extent of branch retinal vein occlusion (BRVO) and the incidence of serous retinal detachment (SRD) in the macular area.
Methods: One hundred nine eyes of 109 consecutive patients with BRVO comprised the study population. These eyes were characterized as having either macular BRVO or major BRVO. We compared the tomographic macular findings between the two groups.
Results: Thirty-nine eyes had macular BRVO, and 70 eyes had major BRVO. The incidence of SRD was higher in the group with major BRVO (63%) than in the group with macular BRVO (21%) (P < 0.001). The incidence of cystoid macular edema was similar in both groups (macular BRVO, 97%; and major BRVO, 90%). Foveal thickness of major BRVO (610 +/- 190 micro m) was significantly greater than that of macular BRVO (500 +/- 140 micro m) (P < 0.01). There was no significant difference in thickness of the neurosensory retina between the group with macular BRVO (450 +/- 120 micro m) and the group with major BRVO (480 +/- 140 micro m).
Conclusions: Serous macular detachment occurs more frequently in major BRVO than in macular BRVO. Vascular leakage from congested retinal veins outside the macular area appears to be a major source of subretinal fluid at the fovea.
Similar articles
-
Aqueous vascular endothelial growth factor levels are associated with serous macular detachment secondary to branch retinal vein occlusion.Retina. 2010 Feb;30(2):281-6. doi: 10.1097/IAE.0b013e3181b9f153. Retina. 2010. PMID: 19881397
-
[Serous macular detachment combined with branch retinal vein occlusion].Nippon Ganka Gakkai Zasshi. 2005 Jun;109(6):362-7. Nippon Ganka Gakkai Zasshi. 2005. PMID: 16047944 Japanese.
-
Delayed absorption of macular edema accompanying serous retinal detachment after grid laser treatment in patients with branch retinal vein occlusion.Ophthalmology. 2004 Nov;111(11):2050-6. doi: 10.1016/j.ophtha.2004.04.031. Ophthalmology. 2004. PMID: 15522371
-
Branch retinal vein occlusion: clinical findings, natural history, and management.Compr Ophthalmol Update. 2006 Nov-Dec;7(6):265-76. Compr Ophthalmol Update. 2006. PMID: 17244442 Review.
-
Branch retinal vein occlusion: epidemiology, pathogenesis, risk factors, clinical features, diagnosis, and complications. An update of the literature.Retina. 2013 May;33(5):901-10. doi: 10.1097/IAE.0b013e3182870c15. Retina. 2013. PMID: 23609064 Review.
Cited by
-
Prevalence of Serous Macular Detachment in Recurrent Macular Edema Secondary to Retinal Vein Occlusion.Turk J Ophthalmol. 2022 Aug 25;52(4):276-280. doi: 10.4274/tjo.galenos.2021.02582. Turk J Ophthalmol. 2022. PMID: 36017487 Free PMC article.
-
Risk factors for repeated dexamethasone intravitreal implant therapy for macular edema due to treatment-naïve branch retinal vein occlusion.BMC Ophthalmol. 2021 Mar 20;21(1):142. doi: 10.1186/s12886-021-01904-8. BMC Ophthalmol. 2021. PMID: 33743610 Free PMC article.
-
Comparison of the efficacy of intravitreal triamcinolone acetonide for cystoid macular edema with versus without serous retinal detachment in branch retinal vein occlusion: influence on macular sensitivity and morphology.BMC Ophthalmol. 2012 Aug 9;12:39. doi: 10.1186/1471-2415-12-39. BMC Ophthalmol. 2012. PMID: 22876931 Free PMC article.
-
Intravitreal bevacizumab for treatment of serous macular detachment in central retinal vein occlusion.Graefes Arch Clin Exp Ophthalmol. 2011 Apr;249(4):513-20. doi: 10.1007/s00417-010-1551-2. Epub 2010 Nov 4. Graefes Arch Clin Exp Ophthalmol. 2011. PMID: 21053008
-
Effect of intravitreal ranibizumab on serous retinal detachment in branch retinal vein occlusion.Clin Ophthalmol. 2018 Aug 17;12:1465-1470. doi: 10.2147/OPTH.S162019. eCollection 2018. Clin Ophthalmol. 2018. PMID: 30154642 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical